Anti-HIV-1 activity of a panel of antimetabolite drugs used in cancer treatment was evaluated in MDMs in the presence or absence of SAMHD1, after transducing cells with HIV-2 Vpx (Figure 1A). The gene discussed is SAMHD1; the disease is cancer.